AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants Medical Device Investing
Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006 Pharmaceutical Investing
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly Biotech Investing
Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05 Pharmaceutical Investing
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock Pharmaceutical Investing
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary Pharmaceutical Investing
Xanthic Biopharma Inc. President, Gary Galitsky and Board Member, Dr. Gunther Hintz, Advance Cannabis Opportunity In Thailand Cannabis Investing News
Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine Pharmaceutical Investing
Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform Biotech Investing
Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial Pharmaceutical Investing
